Chinese hospitals 15% mark up encourages use of expensive drugs, how can we change this?
We asked Dr John Cai if the Chinese hospitals 15% mark up encourages use of expensive drugs? If so, how can we change this?
DetailsWe asked Dr John Cai if the Chinese hospitals 15% mark up encourages use of expensive drugs? If so, how can we change this?
DetailsInterview with Dr John Cai, a highly experienced economist and health economist with 20 years’ experience in both China and the US. John is a Senior Health Policy Analyst at the Massachusetts Executive Office of Health and Human Services in the U.S. heor.tv
DetailsOne of our Twitter followers @HealthEcoDigest recently blogged a podcast with the BMJ editor-in-chief Fiona Godlee and neuroscientist Professor Colin Blakemore. In the podcast, they are discussing whether a false…
DetailsMedicine is not an exact science, so patients are left to understand its nuances without a basic primer in statistics. How do patients understand risk and make their health care decisions? Part of it involves delusion.
Detailsheor.tv inteviewed Marilyn Dix Smith, Founding Executive Director of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and asked How was ISPOR founded and how much has it changed over the years?
Detailsheor.tv inteviewed Marilyn Dix Smith, Founding Executive Director of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and asked about its impact on patient healthcare.
Details‘Ghostwriting’ is a contentious issue among both medical practitioners and medical writers. Outside these circles, this issue typically only surfaces when either a politician decides to deplore it or a pharmaceutical company is implicated.
DetailsThe statistics are staggering. According to one study, the average office worker is interrupted every 11 minutes and takes 25 minutes to return to the original task. Another estimate is…
DetailsDuncan Dibble and Ruth Whittington speak to Jeff Trotter about observational research and its place in the changing health technology assessment (HTA) environment. heor.tv is a collaboration between http://www.healtheconomicsdigest.com and https://www.rxcomms.com
Detailsheor.tv interview Diana Brixner, former president of ISPOR and asked her how important good communications are with respect to rational decision making in the context of evidence supporting market access and reimbursement.
Details